We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M Turnover 13.46%
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+11.23%
1 Year Est. Return
+46.57%
3 Year Est. Return
+105.97%
5 Year Est. Return
+154.19%
10 Year Est. Return
–
AUM
$149M
AUM Growth
+$12.4M
Cap. Flow
+$108K
Cap. Flow %
0.07%
Top 10 Hldgs %
53.42%
Holding
109
New
9
Increased
17
Reduced
49
Closed
5
Avg Time Held Equity + Options
5.3 years
Top 10 Avg Time Held Equity + Options
4.4 years
Top 20 Avg Time Held Equity + Options
3.8 years
Avg Time Held Equity only
5.3 years
Top 10 Avg Time Held Equity only
4.4 years
Top 20 Avg Time Held Equity only
3.8 years

Sector Composition

Rank Sector Weight
1 Healthcare 25.9%
2 Technology 24.13%
3 Energy 12.64%
4 Financials 11.01%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ET icon
26
Energy Transfer Partners
ET
$68.5B
$1.31M 0.88%
94,611
+72,493
+328% +$985K
2021 Q2
10 quarters
KLIC icon
27
Kulicke & Soffa
KLIC
$4.35B
$1.24M 0.83%
22,585
-665
-3% -$32.3K
2021 Q4
8 quarters
SPY icon
28
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$1.15M 0.77%
2,415
– –
2014 Q1
39 quarters
VZ icon
29
Verizon
VZ
$184B
$1.11M 0.75%
29,471
+755
+3% +$26.7K
2013 Q4
40 quarters
PL icon
30
Planet Labs
PL
$5.29B
$1.09M 0.73%
441,425
-1,000
-0.2% -$2.37K
2023 Q2
2 quarters
OKE icon
31
Oneok
OKE
$57.1B
$1.06M 0.71%
15,035
+200
+1% +$13.4K
2015 Q3
33 quarters
SA
32
Seabridge Gold
SA
$2.81B
$1.03M 0.69%
84,930
-300
-0.4% -$3.45K
2013 Q4
40 quarters
REGN icon
33
Regeneron Pharmaceuticals
REGN
$82B
$1.01M 0.68%
1,147
+100
+10% +$82.3K
2021 Q1
11 quarters
DAIO icon
34
Data I/O
DAIO
$27.9M
$1.01M 0.68%
342,350
-1,900
-0.6% -$6.12K
2013 Q4
40 quarters
CSCO icon
35
Cisco
CSCO
$433B
$980K 0.66%
19,400
-500
-3% -$25.5K
2013 Q4
40 quarters
SYF icon
36
Synchrony
SYF
$24.1B
$960K 0.65%
25,150
– –
2018 Q3
21 quarters
AAPL icon
37
Apple
AAPL
$4.99T
$918K 0.62%
4,770
-266
-5% -$49.1K
2013 Q4
40 quarters
INVE icon
38
INVE Technologies, Inc. Common Stock
INVE
$55.5M
$884K 0.59%
107,299
-825
-0.8% -$5.82K
2019 Q3
17 quarters
WMB icon
39
Williams Companies
WMB
$84.7B
$847K 0.57%
24,330
-350
-1% -$12.3K
2013 Q4
40 quarters
ABBV icon
40
AbbVie
ABBV
$501B
$842K 0.57%
5,431
– –
2014 Q2
38 quarters
HESM icon
41
Hess Midstream
HESM
$3.93B
$817K 0.55%
25,830
-5,000
-16% -$153K
2018 Q2
22 quarters
PUBM icon
42
PubMatic
PUBM
$812M
$763K 0.51%
46,810
-200
-0.4% -$2.9K
2021 Q4
8 quarters
POWI icon
43
Power Integrations
POWI
$2.51B
$755K 0.51%
9,200
-800
-8% -$61.3K
2013 Q4
40 quarters
IVAC icon
44
DELISTED
Intevac Inc
IVAC
$743K 0.5%
171,885
-1,490
-0.9% -$5.55K
2020 Q1
15 quarters
SKY icon
45
Champion Homes
SKY
$4.34B
$720K 0.48%
9,700
+121
+1% +$7.61K
2023 Q2
2 quarters
IBM icon
46
IBM
IBM
$221B
$718K 0.48%
4,390
+140
+3% +$21.2K
2022 Q1
7 quarters
CVS icon
47
CVS Health
CVS
$118B
$687K 0.46%
8,700
+50
+0.6% +$3.56K
2019 Q2
18 quarters
BLFS icon
48
DELISTED
BioLife Solutions
BLFS
$665K 0.45%
40,950
-550
-1% -$7.02K
2019 Q2
18 quarters
QQQ icon
49
Invesco QQQ Trust
QQQ
$487B
$657K 0.44%
1,605
-100
-6% -$38K
2018 Q3
21 quarters
KOPN icon
50
Kopin
KOPN
$688M
$655K 0.44%
322,575
-2,500
-0.8% -$3.57K
2016 Q2
30 quarters

Similar funds

Penbrook Management's Q4 2023 Portfolio in Review

As of Q4 2023, Penbrook Management held 109 positions worth $149M, up 9.1% from $136M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Penbrook Management's Q4 2023 filing shows 9 new, 17 increased, 49 reduced and 5 closed positions. Its largest new stake was NPK International: 86,835 shares worth $577K. The largest sale was Crestwood Equity Partners LP, an estimated $1.01M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Energy.

  • Penbrook Management's largest Q4 2023 buy was NPK International: 86,835 shares worth $577K.
  • Penbrook Management added most to Energy Transfer Partners in Q4 2023, an estimated $985K increase.
  • Penbrook Management's biggest Q4 2023 reduction was Novo Nordisk, cutting an estimated $396K.
  • Penbrook Management fully exited Crestwood Equity Partners LP in Q4 2023, selling an estimated $1.01M.
  • Penbrook Management's ten largest holdings make up 53% of its $149M portfolio in Q4 2023.
  • Penbrook Management opened 9 new positions and closed 5 in Q4 2023.
  • Penbrook Management's portfolio value rose 9.1% quarter-over-quarter to $149M.

Based on Penbrook Management's 13F filing for Q4 2023, filed 16 Jan 2024.